These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17657516)

  • 1. CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.
    Voss K; Stahl S; Schleider E; Ullrich S; Nickel J; Mueller TD; Felbor U
    Neurogenetics; 2007 Nov; 8(4):249-56. PubMed ID: 17657516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein.
    Voss K; Stahl S; Hogan BM; Reinders J; Schleider E; Schulte-Merker S; Felbor U
    Hum Mutat; 2009 Jun; 30(6):1003-11. PubMed ID: 19370760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
    Zheng X; Xu C; Di Lorenzo A; Kleaveland B; Zou Z; Seiler C; Chen M; Cheng L; Xiao J; He J; Pack MA; Sessa WC; Kahn ML
    J Clin Invest; 2010 Aug; 120(8):2795-804. PubMed ID: 20592472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
    Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
    Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
    Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
    Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.
    Draheim KM; Li X; Zhang R; Fisher OS; Villari G; Boggon TJ; Calderwood DA
    J Cell Biol; 2015 Mar; 208(7):987-1001. PubMed ID: 25825518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
    Yoruk B; Gillers BS; Chi NC; Scott IC
    Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
    Pagenstecher A; Stahl S; Sure U; Felbor U
    Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
    Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
    Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta.
    Tanriover G; Seval Y; Sati L; Gunel M; Demir N
    Histol Histopathol; 2009 Oct; 24(10):1287-94. PubMed ID: 19688696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
    Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
    Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity.
    Li X; Zhang R; Zhang H; He Y; Ji W; Min W; Boggon TJ
    J Biol Chem; 2010 Jul; 285(31):24099-107. PubMed ID: 20489202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCM3/PDCD10 heterodimerizes with germinal center kinase III (GCKIII) proteins using a mechanism analogous to CCM3 homodimerization.
    Ceccarelli DF; Laister RC; Mulligan VK; Kean MJ; Goudreault M; Scott IC; Derry WB; Chakrabartty A; Gingras AC; Sicheri F
    J Biol Chem; 2011 Jul; 286(28):25056-64. PubMed ID: 21561863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GCKIII (Germinal Center Kinase III) Kinases STK24 and STK25 (Serine/Threonine Kinase 24 and 25) Inhibit Cavernoma Development.
    Sartages M; García-Colomer M; Iglesias C; Howell BW; Macía M; Peña P; Pombo CM; Zalvide J
    Stroke; 2022 Mar; 53(3):976-986. PubMed ID: 35130716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study.
    Scimone C; Bramanti P; Ruggeri A; Donato L; Alafaci C; Crisafulli C; Mucciardi M; Rinaldi C; Sidoti A; D'Angelo R
    BMC Med Genet; 2016 Oct; 17(1):74. PubMed ID: 27737651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
    Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
    Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of CCM1, CCM2 and CCM3 in a Han Chinese cohort with multiple cerebral cavernous malformations in Taiwan.
    Jih KY; Chung CP; Chang YY; Hung PL; Soong BW; Liao YC; Lan MY; Lee YC
    Clin Genet; 2018 Oct; 94(3-4):389-390. PubMed ID: 29787619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.